<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Valcek A</submitter><funding>Charles University Research Fund PROGRES</funding><funding>Ministry of Education Youth and Sports of the Czech Republic</funding><funding>National Sustainability Program I</funding><funding>Horizon 2020</funding><funding>OH-EJP-H2020-JRP-AMR-2-ARDIG</funding><funding>Internal Grant Agency of University of Veterinary and Pharmaceutical Sciences Brno</funding><funding>Czech Science Foundation</funding><funding>Utrecht University</funding><pagination>AAC.02556-20</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8092906</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>65(5)</volume><pubmed_abstract>The relatedness of the equine-associated &lt;i>Escherichia coli&lt;/i> ST1250 and its single- and double-locus variants (ST1250-SLV/DLV), obtained from horses in Europe, was studied by comparative genome analysis. A total of 54 isolates of &lt;i>E. coli&lt;/i> ST1250 and ST1250-SLV/DLV from healthy and hospitalized horses across Europe [Czech Republic (n=23), the Netherlands (n=18), Germany (n=9), Denmark (n=3) and France (n=1)] from 2008-2017 were subjected to whole-genome sequencing. An additional 25 draft genome assemblies of &lt;i>E. coli&lt;/i> ST1250 and ST1250-SLV/DLV were obtained from the public databases. The isolates were compared for genomic features, virulence genes, clade structure and plasmid content. The complete nucleotide sequences of eight IncHI1/ST9 and one IncHI1/ST2 plasmids were obtai</pubmed_abstract><journal>Antimicrobial agents and chemotherapy</journal><pubmed_title>Horsing around: &lt;i>Escherichia coli&lt;/i> ST1250 of equine origin harbouring epidemic IncHI1/ST9 plasmid with &lt;i>bla&lt;/i> &lt;sub>CTX-M-1&lt;/sub> and an operon for short-chain fructooligosaccharides metabolism.</pubmed_title><pmcid>PMC8092906</pmcid><funding_grant_id>116/2015/FVL</funding_grant_id><funding_grant_id>CZ.02.1.01/0.0/0.0/16_019/0000787</funding_grant_id><funding_grant_id>204/2020/FVHE</funding_grant_id><funding_grant_id>Q39</funding_grant_id><funding_grant_id>LO1503</funding_grant_id><funding_grant_id>773830</funding_grant_id><funding_grant_id>18-23532S</funding_grant_id><pubmed_authors>Brouwer MSM</pubmed_authors><pubmed_authors>Jamborova I</pubmed_authors><pubmed_authors>Wagenaar JA</pubmed_authors><pubmed_authors>van Duijkeren E</pubmed_authors><pubmed_authors>Valcek A</pubmed_authors><pubmed_authors>Hrabak J</pubmed_authors><pubmed_authors>Sismova P</pubmed_authors><pubmed_authors>Damborg P</pubmed_authors><pubmed_authors>Ewers C</pubmed_authors><pubmed_authors>Hasman H</pubmed_authors><pubmed_authors>Nesporova K</pubmed_authors><pubmed_authors>Overballe-Petersen S</pubmed_authors><pubmed_authors>Madec JY</pubmed_authors><pubmed_authors>Dolejska M</pubmed_authors><pubmed_authors>Kant A</pubmed_authors><pubmed_authors>Hordijk J</pubmed_authors><pubmed_authors>Bitar I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Horsing around: &lt;i>Escherichia coli&lt;/i> ST1250 of equine origin harbouring epidemic IncHI1/ST9 plasmid with &lt;i>bla&lt;/i> &lt;sub>CTX-M-1&lt;/sub> and an operon for short-chain fructooligosaccharides metabolism.</name><description>The relatedness of the equine-associated &lt;i>Escherichia coli&lt;/i> ST1250 and its single- and double-locus variants (ST1250-SLV/DLV), obtained from horses in Europe, was studied by comparative genome analysis. A total of 54 isolates of &lt;i>E. coli&lt;/i> ST1250 and ST1250-SLV/DLV from healthy and hospitalized horses across Europe [Czech Republic (n=23), the Netherlands (n=18), Germany (n=9), Denmark (n=3) and France (n=1)] from 2008-2017 were subjected to whole-genome sequencing. An additional 25 draft genome assemblies of &lt;i>E. coli&lt;/i> ST1250 and ST1250-SLV/DLV were obtained from the public databases. The isolates were compared for genomic features, virulence genes, clade structure and plasmid content. The complete nucleotide sequences of eight IncHI1/ST9 and one IncHI1/ST2 plasmids were obtai</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-05-07T22:14:55.266Z</modification><creation>2024-11-08T20:59:46.721Z</creation></dates><accession>S-EPMC8092906</accession><cross_references><pubmed>33619063</pubmed><doi>10.1128/aac.02556-20</doi><doi>10.1128/AAC.02556-20</doi></cross_references></HashMap>